Economic evaluation of neoadjuvant chemotherapy for operable breast cancer.

被引：0
|
作者：
Zdenkowski, Nicholas
D'Silva, Shefi Mary
Lawson, Kenny
Reeves, Penny
Boyle, Frances M.
机构：
[1] Univ Newcastle, Callaghan, NSW, Australia
[2] Hunter Med Res Inst, New Lambton Hts, NSW, Australia
[3] Univ Sydney, Sydney, NSW, Australia
[4] Mater Hosp, Sydney, NSW, Australia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12637
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Impact of time to surgery after neoadjuvant chemotherapy in patients with operable breast cancer
    Piacentini, F.
    Filieri, M. E.
    Grizzi, G.
    Omarini, C.
    Maur, M.
    Guaitoli, G.
    Tazzioli, G.
    Madrigali, S.
    Caggia, F.
    Luppi, G.
    ANNALS OF ONCOLOGY, 2015, 26 : 4 - 5
  • [42] Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
    Wang, Huan
    Mao, Xiaoyun
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2020, 14 : 2423 - 2433
  • [43] Predicitve factors for neoadjuvant chemotherapy in locally advanced breast cancer.
    Perez, MA
    Ruiz, J
    Astudillo, H
    Silva, M
    Silva, J
    Pluma, MA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 91S - 91S
  • [44] Results of a novel neoadjuvant chemotherapy (NAC) regimen for breast cancer.
    Rivera-Rodriguez, Noridza
    Cabanillas, Fernando
    Lawrenson, Lesley
    Negron, Viviana
    Pavia, Orestes Antonio
    Bruno, Margarita
    Echenique, Miguel M.
    Carlo, Victor
    Liboy, Idalia
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [45] Effect of neoadjuvant chemotherapy on immune checkpoint expression in breast cancer.
    Stiff, Andrew
    McQuinn, Christopher
    Wesolowski, Robert
    Lustberg, Maryam B.
    Reinbolt, Raquel E.
    VanDeusen, Jeffrey Bryan
    Sardesai, Sagar D.
    Williams, Nicole Olivia
    Noonan, Anne M.
    Dewani, Shabana Jaynul
    Ramaswamy, Bhuvaneswari
    Carson, William Edgar
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [46] Predictive factors of no response during neoadjuvant chemotherapy in breast cancer.
    Jo, Jungmin
    Yoo, Changhoon
    Kim, Jeong-Eun
    Ahn, Jin-Hee
    Kim, Sung-Bae
    Kim, Hak-Hee
    Cha, Joo Hee
    Shin, Hee Jung
    Ahn, Sei-Hyun
    Son, Byung Ho
    Lee, Jong Won
    Kim, Hee Jeong
    Gong, Gyungyub
    Jung, Kyung Hae
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [47] Predictive factors before and after neoadjuvant chemotherapy for breast cancer.
    Pestalozzi, BC
    Caduff, R
    Rageth, C
    Fink, D
    Varga, Z
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 76S - 76S
  • [48] Coil insertion prior to neoadjuvant chemotherapy in patients with breast cancer.
    Sever, AR
    Jones, SE
    Humphreys, VS
    Weeks, J
    Jones, PA
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S57 - S57
  • [49] Impact of Chemotherapy-Induced Amenorrhea on Response to Neoadjuvant Chemotherapy in Breast Cancer.
    Ahn, S. K.
    Moon, H. G.
    Kim, J. S.
    You, J. M.
    Shin, H. C.
    Han, W.
    Noh, D-Y
    CANCER RESEARCH, 2011, 71
  • [50] Neoadjuvant chemotherapy increases rates of breast-conserving surgery in early operable breast cancer
    Man, Vivian C. M.
    Cheung, Polly S. Y.
    HONG KONG MEDICAL JOURNAL, 2017, 23 (03) : 251 - 257
12345